Blood Res.  2017 Dec;52(4):237-239. 10.5045/br.2017.52.4.237.

Unravelling the genomic landscape of leukemia using NGS techniques: the challenge remains

• Kim J

• KMID: 2405056
• DOI: http://doi.org/10.5045/br.2017.52.4.237

Abstract

No abstract available.

MeSH Terms

Leukemia*

Reference

1. Jaffe ES. Pathology and genetics: Tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press;2003.

2. Swerdlow SH, Campo E, Harris NL, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: IARC Press;2008.

3. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127:2375–2390.

4. Maciejewski JP, Tiu RV, O'Keefe C. Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies. Br J Haematol. 2009; 146:479–488.

5. Gulley ML, Shea TC, Fedoriw Y. Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia. J Mol Diagn. 2010; 12:3–16.

6. Ley TJ, Mardis ER, Ding L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature. 2008; 456:66–72.

7. White BS, DiPersio JF. Genomic tools in acute myeloid leukemia: From the bench to the bedside. Cancer. 2014; 120:1134–1144.

8. Sun Y, Ruivenkamp CA, Hoffer MJ, et al. Next-generation diagnostics: gene panel, exome, or whole genome? Hum Mutat. 2015; 36:648–655.

9. Kansal R. Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification. Cancer Biol Med. 2016; 13:41–54.

10. Braggio E, Egan JB, Fonseca R, Stewart AK. Lessons from next-generation sequencing analysis in hematological malignancies. Blood Cancer J. 2013; 3:e127.